Revolution Medicines
RVMD
RVMD
135 hedge funds and large institutions have $2.07B invested in Revolution Medicines in 2022 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
135
Holders Change
-7
Holders Change %
-4.93%
% of All Funds
2.18%
Holding in Top 10
12
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+9.09%
% of All Funds
0.19%
New
18
Increased
52
Reduced
41
Closed
23
Calls
$3.85M
Puts
$748K
Net Calls
+$3.1M
Net Calls Change
+$2.02M
Top Buyers
| 1 |
EC
EcoR1 Capital
San Francisco,
California
|
$106M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
$211M |
| 3 |
AG
Artal Group
Luxembourg
|
$23.8M |
| 4 |
JPMorgan Chase & Co
New York
|
$61.8M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
$180M |
Top Sellers
| 1 |
DM
Deerfield Management
New York
|
$21.2M |
| 2 |
TGI
TRV GP III
Boston,
Massachusetts
|
$38.2M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
$40.4M |
| 4 |
State Street
Boston,
Massachusetts
|
$90.1M |
| 5 |
Millennium Management
New York
|
$2.8M |
